Genetic and epigenetic changes in lung carcinoma and their clinical implications
Authors:
- 1 July 2011
- journal article
- research article
- Published by Elsevier in Laboratory Investigation
- Vol. 24 (7) , 932-943
Abstract
No abstract availableKeywords
This publication has 137 references indexed in Scilit:
- Epidermal growth factor receptor inhibition in lung cancer: the evolving role of individualized therapyCancer and Metastasis Reviews, 2010
- Altered miRNA expression in sputum for diagnosis of non-small cell lung cancerLung Cancer, 2010
- MicroRNA 133B targets pro-survival molecules MCL-1 and BCL2L2 in lung cancerBiochemical and Biophysical Research Communications, 2009
- DLEC1 and MLH1 promoter methylation are associated with poor prognosis in non-small cell lung carcinomaBritish Journal of Cancer, 2008
- Expression of methylation-related genes is associated with overall survival in patients with non-small cell lung cancerBritish Journal of Cancer, 2008
- Characterizing the cancer genome in lung adenocarcinomaNature, 2007
- LKB1 modulates lung cancer differentiation and metastasisNature, 2007
- Prevalence and specificity of LKB1 genetic alterations in lung cancersOncogene, 2007
- MicroRNA Signatures in Human CancersNature Reviews Cancer, 2006
- Epidermal growth factor receptor variant III mutations in lung tumorigenesis and sensitivity to tyrosine kinase inhibitorsProceedings of the National Academy of Sciences, 2006